55390-0164 Octreotide Acetate - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

55390-0164

Brand Name:

Octreotide Acetate

Generic Name:

Octreotide Acetate

Dosage Form Name:

Injection

Administration Route:

Substances:

Packages:

Code: 55390-0164-01

Description:

Effective Date: April 8, 2005

Discontinued: Dec. 31, 2014

SEER*Rx Category:

Hormonal Therapy

Major Class:

Somatostatin Analog

Minor Class:

Orphan Drug Designation:

Yes

Status:

No Longer Used